Christopher Pieczonka
0000-0002-2531-7587
5 papers found
Refreshing results…
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial
Development and evaluation of the MiCheck test for aggressive prostate cancer
The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial
Missing publications? Search for publications with a matching author name.